Riyadh
Saudi Arabia · 5 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| population | Saudi Arabia, Riyadh | “Molecular characterization and genotypic diversity of human astroviruses among patients with gastroenteritis in Saudi Arabia, 2022-2023. This study investigated the molecular diversity of human astroviruses in Riyadh, Saudi Arabia. Among the HAstV-positive cases, 8 patients (50%) were male and 8 (50%) were female.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “Establishment of the first nationwide registry for inherited hemoglobin and blood-related disorders (IHBD) in Saudi Arabia: design and clinical evaluation. BACKGROUND: Inherited hemoglobinopathies, particularly sickle cell disease (SCD) and thalassemia, represent a major public health burden in Saudi Arabia. This study describes the development, governance framework, and epidemiological characterization of the Saudi National Inherited Hemoglobin and Blood Disorders (IHBD) Registry and reports population-level patterns derived from unified Ministry of Health (MOH) data integration. IHBD Registry coverage per 100,000 population was calculated using the 2024 Saudi census estimate. RESULTS: After deduplication, 105,008 unique patients with inherited blood disorders were identified, corresponding to approximately 298 patients per 100,000 population in the IHBD Registry. Geographic clustering was observed, with the Eastern (32.0%), Makkah (28.1%), and Riyadh (19.1%) regions accounting for the majority of registered cases.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “We report 8 patients with sickle cell disease (SCD) who developed PRES, which is likely to be related to immunosuppression. METHODS: This is retrospective cohort analysis of the SCD registry at the King Faisal Specialist Hospital and Research Center (KFSHRC) in Riyadh, Saudi Arabia.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “PURPOSE: The aim of this study was to report the detailed ophthalmic findings in a young patient with genetically confirmed arterial tortuosity syndrome (ATS) and the findings in 8 family members who were carriers. METHODS: Nine members of the same Saudi family were assessed at King Khaled Eye Specialist Hospital in Riyadh, Saudi Arabia, for ATS-related ocular changes after homozygosity for the pathogenic variant of SLC2A10 gene was confirmed in 1 member.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “METHODS: This observational study with consecutive sampling took place in King Fahad Medical City, Riyadh, Saudi Arabia. RESULTS: We were able to lateralize speech dominance in 8 patients and memory dominance in 6 patients.” | 0.95 | saudi_context_rules_v1 |